7 Hills Pharma

OverviewSuggest Edit

7 Hills Pharma is an immuno-oncology company offering solutions to treat drug-resistant cancers. It develops technologies that modulate the immune system to increase the effectiveness of immune checkpoint blockade, adoptive cell therapy, and cord blood transplant to treat solid tumors and orphan genetic diseases.
TypePrivate
Founded1995
HQHouston, TX, US
Website7hillspharma.com

Latest Updates

Employees (est.) (Oct 2021)5(+25%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at 7 Hills Pharma

Upendra Marathi

Upendra Marathi

President & CEO
Lionel Lewis

Lionel Lewis

Chief Medical Officer
Richard Dixon

Richard Dixon

Co-Founder & Manager
Show more

7 Hills Pharma Office Locations

7 Hills Pharma has an office in Houston
Houston, TX, US (HQ)
2450 Holcombe Blvd suite j
Show all (1)

7 Hills Pharma Financials and Metrics

Summary Metrics

Founding Date

1995

7 Hills Pharma total Funding

$2 m

7 Hills Pharma latest funding size

$2 m

Time since last funding

3 years ago

7 Hills Pharma investors

7 Hills Pharma's latest funding round in June 2018 was reported to be $2 m. In total, 7 Hills Pharma has raised $2 m
Show all financial metrics

7 Hills Pharma Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

7 Hills Pharma Online and Social Media Presence

Embed Graph

7 Hills Pharma News and Updates

Texas Heart Institute, University of Texas Medical Branch (UTMB) and 7 Hills Pharma Pioneer Significant Vaccine Research

New Study Asserts That the 7HP349 Integrin Activator Compound Has the Ability to Augment Vaccine Effectiveness by Boosting Immune Response Following Inoculation New Study Asserts That the 7HP349 Integrin Activator Compound Has the Ability to Augment Vaccine Effectiveness by Boosting Immune Response …

7 Hills Pharma Names Biopharma Industry Veteran Michael S. Perry Chairman of its Board of Managers

Company advancing small molecule integrin activators to enhance immuno-oncology drugs and infectious disease vaccines, including COVID-19 Company advancing small molecule integrin activators to enhance immuno-oncology drugs and infectious disease vaccines, including COVID-19

7 Hills Pharma Announces First Healthy Volunteers Dosed in Landmark Phase 1 Trial of Immunostimulant to Improve Immuno-Oncology Drugs, COVID-19 and Influenza Vaccines

Strengthening immunotherapies is especially critical for older adults with weakened immune systems Strengthening immunotherapies is especially critical for older adults with weakened immune systems

7 Hills Pharma Receives $2M SBIR Grant from NCI to Launch Phase 1 Trials of Lead Immunostimulant to Augment Immuno-Oncology Drugs, COVID-19 and Flu Vaccines

HOUSTON, Sept. 16, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases, has been awarded a two-year, $2 million Small Business Innovation Research (SBIR) grant from the Na…

7 Hills Pharma Frequently Asked Questions

  • When was 7 Hills Pharma founded?

    7 Hills Pharma was founded in 1995.

  • Who are 7 Hills Pharma key executives?

    7 Hills Pharma's key executives are Upendra Marathi, Lionel Lewis and Richard Dixon.

  • How many employees does 7 Hills Pharma have?

    7 Hills Pharma has 5 employees.

  • Who are 7 Hills Pharma competitors?

    Competitors of 7 Hills Pharma include Day One Biopharmaceuticals, Numab and CARsgen Therapeutics.

  • Where is 7 Hills Pharma headquarters?

    7 Hills Pharma headquarters is located at 2450 Holcombe Blvd suite j, Houston.

  • Where are 7 Hills Pharma offices?

    7 Hills Pharma has an office in Houston.

  • How many offices does 7 Hills Pharma have?

    7 Hills Pharma has 1 office.